Dilon Technologies delivers enhanced imaging capabilities

Jun 16 2009

Dilon Technologies, Inc., the leader in molecular breast imaging, today announced the release of the newest Dilon 6800 Software update including enhancements for both breast and general nuclear medicine applications image processing. The new software functionalities complement the Slant15 Collimator for breast imaging and the Low Energy High-Resolution (LEHR) Collimator for general nuclear medicine applications, both released earlier this year as purchase options for the Dilon 6800 gamma camera.

Processing protocols for pediatric lung and renal, as well as gallbladder imaging and ejection studies are now standard in the Dilon 6800 software package. Detailed images for these protocols can be acquired utilizing Dilon's new high resolution collimator. These additional features help broaden the versatility of the Dilon 6800 gamma camera beyond breast, thyroid, sentinel node and spot bone imaging to provide additional high-resolution, organ-specific studies to maximize clinical utility and economic benefit.

This compact and mobile system provides the flexibility to image at patient bedside or to move the unit between multiple facilities. Other enhancements include an onscreen measurement toolkit and quantification toolkit useful for various applications, but especially to help determine lesion size and location in breast imaging. In addition, the new software allows for simultaneous processing and acquisition.

The Dilon 6800 has traditionally served as a diagnostic adjunct to mammography to provide breast-specific gamma imaging, BSGI. However, with the addition of the Slant15 and LEHR collimators and expanded software functionalities, facilities are now able to utilize the camera for other general nuclear medicine applications and can maximize clinical patient throughput by using the standard gamma cameras for whole body and SPECT studies- thus offloading studies of smaller body parts to the Dilon 6800.

"While we maintain focus on high quality molecular breast imaging with the Dilon 6800, which has yielded results competitive with breast ultrasound and MRI, we are extending the clinical utility of the Dilon 6800 to improve its overall value to the imaging center," said Douglas Kieper, Vice President of Science and Technology at Dilon Technologies. "We are proud to offer new collimators and software features to provide even more efficiency for a variety of diagnostic imaging procedures."

Dilon Technologies is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; Northwestern Memorial Hospital, Chicago; and The Rose, Houston.